SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-20-001375
Filing Date
2020-10-29
Accepted
2020-10-29 07:38:54
Documents
13
Period of Report
2020-10-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 8-K a52316019.htm   iXBRL 8-K 29024
2 EXHIBIT 99.1 a52316019ex99_1.htm EX-99.1 577668
  Complete submission text file 0001157523-20-001375.txt   779889

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA crl-20201029.xsd EX-101.SCH 4186
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE crl-20201029_lab.xml EX-101.LAB 23692
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crl-20201029_pre.xml EX-101.PRE 16825
6 EXTRACTED XBRL INSTANCE DOCUMENT a52316019_htm.xml XML 4083
Mailing Address 251 BALLARDVALE ST WILMINGTON MA 01887
Business Address 251 BALLARDVALE ST WILMINGTON MA 01887 781-222-6000
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (Filer) CIK: 0001100682 (see all company filings)

IRS No.: 061397316 | Fiscal Year End: 1226
Type: 8-K | Act: 34 | File No.: 001-15943 | Film No.: 201270553
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services